Clover Health Investments (NASDAQ: CLOV) delivered its second consecutive profitable quarter tonight, beating earnings ...

Medicare Advantage-focused insurtech Clover Health saw its revenue climb by 50% year over year in the third quarter, per its ...

Clover Health Investments (CLOV) shared that Chelsea Clinton, the company’s longest-serving board member, will wrap up her board tenure on October 31, 2025. Clinton’s eight-year span on the board ...

Technology company Clover Health announced it will run its in-home primary care program, Clover Home Care, through CMS’ Direct Contracting Model. “The goal of Direct Contracting is to make the ...

Health insurance company Clover Health (NASDAQ:CLOV) announced in Q3 CY2025, with sales up 50.1% year on year to $496.7 ...

Clover's strong HEDIS score and lower churn could offset new members' higher medical costs while potentially driving SaaS ...

Clover Health Investments (CLOV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Detailed price information for Clover Health Investments Corp (CLOV-Q) from The Globe and Mail including charting and trades.